Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2014-06-02 17:08:31 |
Versijas komentārs | |
Teksts |
Olainfarm will
Hold First Quarter 2014 Investor Conference
Webinar
AS „Olainfarm”
invites shareholders, investors, mass media representatives and
other stakeholders to join its first quarter 2014 investor
conference webinar scheduled on June 5, 2014 at 16:00 (EET).
Webinar will be
hosted by the member of the management board Salvis Lapiņš. The
presentation will be in English. During the webinar
Salvis Lapiņš will inform about AS “Olainfarm” latest activities
and analyse the financial results of the first quarter 2014.
After the
presentation investors will be welcomed to ask
questions. Due to the limited webinar time, please send
in your questions in advance till June 4 to e-mail: ieva.kadakovska@nasdaqomx.com.
What is
webinar? How to join the
webinar? Additional
information on the webinar
JSC Olainfarm is one of the biggest pharmaceutical companies in
Latvia with more than 40 years of experience in production of
medication and chemical and pharmaceutical products. A basic
principle of company's operations is to produce reliable and
effective top quality products for Latvia and the rest of the
world. Products made by the Group are being exported to more than
35 countries of the world, including the Baltics, Russia, other
CIS, Europe, Asia, North America and Australia.
Information prepared
by: Salvis
Lapins JSC
“Olainfarm” Member of the Management
Board Rupnicu iela 5, Olaine, Latvia, LV
2114 Phone: +371 6 7013
717 Fax: +371 6 7013
777 e-mail: slapinsh@olainfarm.lv
|
Pielikumi |
|